| Rank | Title | Journal | Year | PubWeight™‹?› |
|---|---|---|---|---|
| 1 | Modulation of NMDA receptor function by inhibition of D-amino acid oxidase in rodent brain. | Neuropharmacology | 2011 | 0.87 |
| 2 | Galanin function in the central nervous system. | Curr Opin Drug Discov Devel | 2006 | 0.85 |
| 3 | Discovery of 4-(5-methyloxazolo[4,5-b]pyridin-2-yl)-1,4-diazabicyclo[3.2.2]nonane (CP-810,123), a novel alpha 7 nicotinic acetylcholine receptor agonist for the treatment of cognitive disorders in schizophrenia: synthesis, SAR development, and in vivo efficacy in cognition models. | J Med Chem | 2010 | 0.80 |
| 4 | 1-[(1-methyl-1H-imidazol-2-yl)methyl]-4-phenylpiperidines as mGluR2 positive allosteric modulators for the treatment of psychosis. | J Med Chem | 2011 | 0.78 |
| 5 | 3-(Imidazolyl methyl)-3-aza-bicyclo[3.1.0]hexan-6-yl)methyl ethers: a novel series of mGluR2 positive allosteric modulators. | Bioorg Med Chem Lett | 2008 | 0.77 |
| 6 | Discovery, synthesis and SAR of azinyl- and azolylbenzamides antagonists of the P2X₇ receptor. | Bioorg Med Chem Lett | 2011 | 0.77 |